In March 2018, UAEM students launched a campaign to press the University of California (UCLA) to drop its patent claim in India on Xtandi, a life-saving prostate cancer medicine (brand name Xtandi) which was developed on its campus with public funds.
Make Medicine for People Not for Profit! #TakeBackXtandi
Join us to urge UCLA and the University of California system to drop the patent claim in India on a life-saving prostate cancer drug developed on campus with tax-payer funds!
We’re in the media:
1. STAT NEWS: Students push UCLA to improve access to drug developed by its researchers https://www.statnews.com/2018/
To learn more or to get engaged please email: firstname.lastname@example.org
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.